Pharmelp counterfeit drug analysis project gains pace
By Phil Taylor
A European project which aims to bring affordable equipment for counterfeit and substandard medicines analysis to countries in the developing world is making progress, with new machines due to be installed in Cambodia and Congo shortly and several more on the way.
The initiative, called Pharmelp, has designed low-cost capillary electrophoresis machines which can easily be set up and operated and provide an effective means to analyse commonly counterfeited medicines. The machines are designed to make use of cheap, easily-sourced parts and do not need costly consumables.
Pharmelp was featured in SecuringPharma.com earlier this year shortly after it installed its first prototype ECB (Electrophorèse capillaire Budget) machine in Mali, a country suffering under a particularly heavy burden of medicines counterfeiting.
Since then, there has been increased attention to the initiative among the scientific community, helped by peer review publications in the Journal of Pharmaceutical and Biomedical Analysis (December 15, 2010) and Chemistry Today (September/October 2010).
Click here to read the entire article.
Special thanks to SecuringPharma.com for the opportunity to reprint this article.